NTRS
35
10
TRV
34
4
NWL
48
4
PNR
56
2
SYK
50
4
NWS
69
5
DE
49
3
DG
14
6
BIIB
36
8
ABT
54
4
NOV
45
2
OMC
37
2
ESS
44
5
MU
42
14
XRX
48
2
ICE
53
5
KMI
69
8
RL
73
5
JCI
44
7
GME
61
2
NTRS
35
10
TRV
34
4
NWL
48
4
PNR
56
2
SYK
50
4
NWS
69
5
DE
49
3
DG
14
6
BIIB
36
8
ABT
54
4
NOV
45
2
OMC
37
2
ESS
44
5
MU
42
14
XRX
48
2
ICE
53
5
KMI
69
8
RL
73
5
JCI
44
7
GME
61
2
Financhill
Back

Offerpad Solutions Vs. Novo Nordisk AS Industry Stock Comparison

Sell
20

OPAD
Offerpad Solutions

Last Price:
$3.50
Seasonality Move:
-9.88%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
20
Offerpad Solutions (OPAD) is a Sell

Is Offerpad Solutions a Buy, Sell or Hold?

  • The current Offerpad Solutions [OPAD] share price is $3.65. The Score for OPAD is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • OPAD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OPAD Stock Price Chart

What is Offerpad Solutions's stock price today?

  • The Offerpad Solutions share price today is $3.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OPAD is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

OPAD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 45.69 Sell
Chaikin Money Flow: 197783 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.56 - 4.54) Sell
Bollinger Bands (100): (3.15 - 4.23) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

OPAD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.74 Sell
20-day SMA: 4.14 Sell
50-day SMA: 3.66 Sell
200-day SMA: 4.92 Sell
8-day EMA: 3.69 Sell
20-day EMA: 3.88 Sell
50-day EMA: 3.85 Sell
200-day EMA: 5.15 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Offerpad Solutions Earnings Growth & OPAD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.14 per share, and an increase next year of $0.73 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

Offerpad Solutions Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):